Table 5 AMR testing of K. pneumoniae isolates with corresponding resistance Genes.
Prevalence of target genes among K. pneumoniae isolates NO. (%) | Antimicrobial Susceptibility Testing of resistant K. pneumoniae Isolates using Kirby–Bauer disc diffusion method | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Amoxicillin -clavulanate NO. (%) | Ceftriaxone NO. (%) | Cefoxitin NO. (%) | Cefuroxime NO. (%) | Ceftazidime NO. (%) | Piperacillin-tazobactam NO. (%) | Imipenem NO. (%) | Meropenem NO. (%) | ||
ESBLs resistance encoding genes | |||||||||
blaTEM 38(92.7) | 37 (97.4) | 35 (92.1) | 33(86.8) | 37(97.4) | 33 (86.8) | 32 (84.2) | 26 (68.4) | 30 (78.9) | |
Carbapenem resistance encoding genes | |||||||||
blaNDM | 39(95.1) | 38(97.4) | 36(92.3) | 34(87.2) | 38(97.4) | 34(87.2) | 33(84.6) | 27 (69.2) | 30 (76.9) |
blaOXA | 39(95.1) | 38 (97.4) | 36 (92.3) | 34 (87.2) | 38(97.4) | 34 (87.2) | 33 (84.6) | 27 (69.2) | 30 (76.9) |
blaVIM | 16(39) | 16(100) | 15(93.8) | 15(93.8) | 16(100) | 15(93.8) | 15(93.8) | 15 (93.8) | 15 (93.8) |
blaIMP | 8(19.5) | 8 (100) | 8 (100) | 8 (100) | 8 (100) | 8 (100) | 8 (100) | 6 (75) | 7 (87.5) |
blaKPC | 6(14.6) | 6 (100) | 5 (83.3) | 5 (83.3) | 6 (100) | 5 (83.3) | 5(83.3) | 5 (83.3) | 5 (83.3) |
Colistin resistance genes | Colistin | ||||||||
mcr-1 | 29(70.7) | 24(82.8) | |||||||
mcr-2 | 27(65.9) | 18(66.7) | |||||||
Aminoglycoside resistance genes | Gentamycin | Amikacin | |||||||
aac(3)-Ia | 5(12.2) | 5(100) | 5(100) | ||||||
aac(3)-IIa | 35 (87.8) | 26(74.3) | 24(68.6) | ||||||
